Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study

Basit Öğe Kaydı
dc.authoridBERBER, Ilhami/0000-0003-3312-8476
dc.authoridDogu, Mehmet Hilmi/0000-0001-7237-2637
dc.authoridAKPINAR, SEVAL/0000-0002-6961-8971
dc.authoridKAYA, Emin/0000-0001-8605-8497
dc.authoridDurusoy, Salih Sertaç/0000-0002-3577-6330
dc.authoridBasturk, Abdulkadir/0000-0003-1864-0316
dc.authoridokan, vahap/0000-0002-9869-8181
dc.authorwosidGURKAN, EMEL/E-8808-2018
dc.authorwosidBERBER, Ilhami/ABI-6231-2020
dc.authorwosidDogu, Mehmet Hilmi/W-2255-2017
dc.authorwosidSaydam, Guray/W-3827-2017
dc.authorwosidAKPINAR, SEVAL/HKD-9650-2023
dc.authorwosid, aliunal/GLQ-6094-2022
dc.authorwosidKAYA, Emin/W-2951-2017
dc.contributor.authorTombak, Anil
dc.contributor.authorTanrikulu, Funda Pepedil
dc.contributor.authorDurusoy, Salih Sertac
dc.contributor.authorGurkan, Emel
dc.contributor.authorKaya, Emin
dc.contributor.authorUmit, Elif G.
dc.contributor.authorYavasoglu, Irfan
dc.date.accessioned2024-08-04T20:58:37Z
dc.date.available2024-08-04T20:58:37Z
dc.date.issued2019
dc.departmentİnönü Üniversitesien_US
dc.description61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) -- DEC 07-10, 2019 -- Orlando, FLen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Soc Hematolen_US
dc.identifier.doi10.1182/blood-2019-126402
dc.identifier.issn0006-4971
dc.identifier.issn1528-0020
dc.identifier.urihttps://doi.org/10.1182/blood-2019-126402
dc.identifier.urihttps://hdl.handle.net/11616/103019
dc.identifier.volume134en_US
dc.identifier.wosWOS:000577164606194en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherAmer Soc Hematologyen_US
dc.relation.ispartofBlooden_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject[No Keywords]en_US
dc.titleEfficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Studyen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu